First occurrence of transferable extended-spectrum beta-lactamase hydrolyzing cefoperazone in multiresistant nosocomial strains of Klebsiella pneumoniae from two hospitals in Czech and Slovak Republics

J Chemother. 2002 Oct;14(5):461-4. doi: 10.1179/joc.2002.14.5.461.

Abstract

The occurrence of positive synergy between antibiotic discs of amoxicillin/clavulanate and cefoperazone was registered in two Klebsiella pneumoniae strains, isolated from hospitals in Czech and Slovak Republic, indicating the presence of genes coding for an extended-spectrum beta-lactamase active also against cefoperazone, a broad-spectrum cephalosporin. Sulbactam inhibited the hydrolysis of cefoperazone by cell-free lysates of these strains which substantiates its use in combination with cefoperazone. Resistance to cephalothin, cefotaxime, ceftazidime, cefoperazone, cefepime and aztreonam was transferred from K. pneumoniae isolates to Escherichia coli K-12 3110 and to Proteus mirabilis P-38 recipient strains.

MeSH terms

  • Amoxicillin-Potassium Clavulanate Combination / pharmacology*
  • Anti-Bacterial Agents / pharmacology*
  • Cefoperazone / pharmacology*
  • Cephalosporins / pharmacology
  • Cross Infection / drug therapy
  • Czech Republic
  • Drug Interactions
  • Drug Resistance, Multiple*
  • Escherichia coli / drug effects
  • Escherichia coli / genetics
  • Humans
  • Hydrolysis
  • Klebsiella Infections / drug therapy*
  • Klebsiella pneumoniae / drug effects*
  • Klebsiella pneumoniae / genetics
  • Klebsiella pneumoniae / pathogenicity
  • Proteus mirabilis / drug effects
  • Proteus mirabilis / genetics
  • Slovakia

Substances

  • Anti-Bacterial Agents
  • Cephalosporins
  • Amoxicillin-Potassium Clavulanate Combination
  • Cefoperazone